Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

por Ono, Takaaki, Hino, Masayuki, Matsumura, Itaru, Fujisawa, Shin, Ishizawa, Kenichi, Sakaida, Emiko, Sekiguchi, Naohiro, Ono, Chiho, Aizawa, Mana, Tanetsugu, Yusuke, Koide, Yuichiro, Takahashi, Naoto
Publicado 2022

Phase I study of glasdegib (PF‐04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies

por Minami, Yosuke, Minami, Hironobu, Miyamoto, Toshihiro, Yoshimoto, Goichi, Kobayashi, Yukio, Munakata, Wataru, Onishi, Yasushi, Kobayashi, Masahiro, Ikuta, Mari, Chan, Geoffrey, Woolfson, Adrian, Ono, Chiho, Shaik, Mohammed Naveed, Fujii, Yosuke, Zheng, Xianxian, Naoe, Tomoki
Publicado 2017